COVID-19 vaccine | Is the Moderna and NIH Partnership 'Rotten To The Core'?

Share the News



Ben Swann takes a look at the highly unusual timeline by which Moderna Therapeutics is developing its COVID-19 virus vaccine

Now, four scientists with the NIH claim they hold partial patent rights on that vaccine and stand to make up to $150,000 per year.

Meanwhile, as Moderna’s stock price continues to soar, five top executives have sold off $89 million dollars worth of shares, even as the company continues to bypass standard vaccine protocols in the development of its COVID vaccine

Subscribe to RT! https://www.youtube.com/channel/UCpwvZwUam-URkxB7g4USKpg?sub_confirmation=1

RT LIVE https://www.youtube.com/watch?v=IFAcqaNzNSc

Check out http://rt.com

Like us on Facebook http://www.facebook.com/RTnews
Follow us on VK https://vk.com/rt_international
Follow us on Twitter http://twitter.com/RT_com
Follow us on Instagram http://instagram.com/rt
Follow us on Soundcloud https://soundcloud.com/rttv

#RT (Russia Today) is a global #news network broadcasting from Moscow, London, Paris and Washington studios to over 100 countries. RT is the first news channel to break the 1 billion YouTube views benchmark.

source